Back to search

Article

Intranasal Delivery of Hypoxia-Primed Wharton’s Jelly MSC-Derived sEVs Reprograms Neuroimmune Signalling and Ameliorates Behavioural Deficits in a Valproic Acid–Induced Mouse Model of Autism Spectrum Disorder

2026-05-27

Abstract excerpt

<h4>Background</h4> Beyond disrupted neurodevelopment, autism spectrum disorder (ASD) encompasses progressive neurodegenerative alterations that remain refractory to standard of care behavioral therapies, highlighting the need for biologically targeted adjunctive interventions. Although, Mesenchymal stem cell (MSC) derived small extracellular vesicles (sEVs) have emerged as potent neuroprotective agents; however,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b6496d09-68fe-517e-a4ca-c053b195e00e
DOI
10.64898/2026.05.24.721255
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Intranasal Delivery of Hypoxia-Primed Wharton’s Jelly MSC-Derived sEVs Reprograms Neuroimmune Signalling and Ameliorates Behavioural Deficits in a Valproic Acid–Induced Mouse Model of Autism Spectrum DisorderDOI 10.64898/2026.05.24.721255
Select a neighboring publication to make it the new centre.